Updated Recommendation for Universal Hepatitis B Vaccination in Adults Aged 19-59 Years - United States, 2024

MMWR Morb Mortal Wkly Rep. 2024 Dec 5;73(48):1106. doi: 10.15585/mmwr.mm7348a3.

Abstract

Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). The Advisory Committee on Immunization Practices recommends universal HepB vaccination for adults aged 19-59 years, including pregnant persons, and adults aged ≥60 years with risk factors for hepatitis B. Adults aged ≥60 years without known risk factors for hepatitis B may also receive HepB vaccines (2).

MeSH terms

  • Adult
  • Centers for Disease Control and Prevention, U.S.*
  • Female
  • Hepatitis B Vaccines* / administration & dosage
  • Hepatitis B* / epidemiology
  • Hepatitis B* / prevention & control
  • Humans
  • Immunization Schedule
  • Male
  • Middle Aged
  • Pregnancy
  • United States / epidemiology
  • Vaccination / statistics & numerical data
  • Young Adult

Substances

  • Hepatitis B Vaccines